Department of Molecular and Clinical Cancer Medicine, University of Liverpool, 6 West Derby Street, Liverpool L7 8TX, UK.
MRC Oxford Institute for Radiation Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK.
Int J Mol Sci. 2023 Mar 3;24(5):4920. doi: 10.3390/ijms24054920.
Radiotherapy (ionising radiation; IR) is utilised in the treatment of ~50% of all human cancers, and where the therapeutic effect is largely achieved through DNA damage induction. In particular, complex DNA damage (CDD) containing two or more lesions within one to two helical turns of the DNA is a signature of IR and contributes significantly to the cell killing effects due to the difficult nature of its repair by the cellular DNA repair machinery. The levels and complexity of CDD increase with increasing ionisation density (linear energy transfer, LET) of the IR, such that photon (X-ray) radiotherapy is deemed low-LET whereas some particle ions (such as carbon ions) are high-LET radiotherapy. Despite this knowledge, there are challenges in the detection and quantitative measurement of IR-induced CDD in cells and tissues. Furthermore, there are biological uncertainties with the specific DNA repair proteins and pathways, including components of DNA single and double strand break mechanisms, that are engaged in CDD repair, which very much depends on the radiation type and associated LET. However, there are promising signs that advancements are being made in these areas and which will enhance our understanding of the cellular response to CDD induced by IR. There is also evidence that targeting CDD repair, particularly through inhibitors against selected DNA repair enzymes, can exacerbate the impact of higher LET, which could be explored further in a translational context.
放射治疗(电离辐射;IR)用于治疗约 50%的人类癌症,其治疗效果主要通过诱导 DNA 损伤来实现。特别是,含有两个或更多损伤的复杂 DNA 损伤(CDD)位于 DNA 的一个至两个螺旋扭转内,是 IR 的特征,并由于其通过细胞 DNA 修复机制进行修复的难度而对细胞杀伤效应有重大贡献。CDD 的水平和复杂性随着 IR 的电离密度(线性能量转移,LET)的增加而增加,因此光子(X 射线)放射疗法被认为是低 LET,而某些粒子离子(如碳离子)则是高 LET 放射疗法。尽管有这些知识,但在细胞和组织中检测和定量测量 IR 诱导的 CDD 仍然存在挑战。此外,对于参与 CDD 修复的特定 DNA 修复蛋白和途径的生物学不确定性,包括 DNA 单链和双链断裂机制的组成部分,存在生物学不确定性,这在很大程度上取决于辐射类型和相关的 LET。然而,有迹象表明,这些领域正在取得进展,这将增强我们对细胞对 IR 诱导的 CDD 的反应的理解。还有证据表明,靶向 CDD 修复,特别是通过针对选定 DNA 修复酶的抑制剂,可以加剧更高 LET 的影响,这在转化背景下可以进一步探索。